Abstract:Background: For the management of hemolytic disease of the fetus and newborn (HDFN), it is important to detect unexpected red cell antibody in pregnant women. We assessed the prevalence of unexpected red cell antibodies in consecutive pregnant women attending antenatal clinic (ANC). More importantly, cases with unexpected antibody causing severe anemia were followed-up for intervention (Intra-uterine transfusion {IUT}) and outcome of pregnancy (still-birth/live-healthy). Aims and objectives: The study was conducted with an objective to find the prevalence of unexpected RBC antibodies in pregnant women, their specificity and to do the follow-up for IUT and outcome of pregnancy (still-birth, live-birth) in antibody positive women. Materials and methods: This was a prospective study from January 2021 to May 2022 at two tertiary care centres. All antenatal samples received by the laboratory were screened for unexpected red cell antibody. Whenever antibody screen was positive, antibody identification was performed. Patients, positive for unexpected antibody and anemia were followed up for any transfusion-based intervention and outcome of pregnancy. Results: A total of 539 consecutive samples were worked up and among these, 10 samples (1.85%) were found to be antibody positive. The antibodies identified were Anti-D (n=6), anti-Leb (n=1), anti-M (n=1), anti-C (n=1) and anti-E (n=1).The prevalence of unexpected antibodies in Rh positive and Rh negative pregnant women was 0.83% and 10.9% respectively. Follow-up was done for all 10 cases with unexpected antibody and anemia was monitored by MCA PSV (middle cerebral artery peak systolic velocity).Two women developed severe anemia thus requiring single intrauterine transfusion (at 26 weeks and 28 weeks respectively) each, for correction of anemia. In both these cases, healthy male child was delivered. At 3-month follow-up both children were alive and healthy. Conclusion: The study found prevalence of unexpected RBC antibodies in pregnant women as 1.85%. The study also underlined importance of transfusion-based interventions contributing to successful outcome in couple of cases with severe anemia.

Application of unexpected antibody detection in Rh negative patient

Clinical Significance of Screening of Rh-negative Blood Group and Detection of Irregular Antibody

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

Analysis of Rh Blood Type Antibody Specificities of Transfused Patients in the Sichuan Area of China

The Necessity of Clinical Rh Phenotypic Serological Detection and Homotypic Infusion in Patients with Repeated Blood Transfusion

Clinical significances and distribution of unexpected antibodies found in infants

The Variation of RhD Blood Group in Different Periods in a Patient with Systemic Lupus Erythematosus

Application of anti-D immunoglobulin in D-negative pregnant women in China

[Analysis of the causes of incompatible cross-matching induced by two Rh blood group antibodies and corresponding laboratory treatment]

Prospective Evaluation of A Transfusion Policy of Rhd-Positive Red Blood Cells into Del Patients in China

[Detection of Rh phenotype in clinical blood transfusion and the necessity of homotype transfusion]

Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China

Secondary Alloanti-D Immunization Post Transfusion of “asia Type” DEL Red Blood Cells

Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion

Comparison of the Detection Rate and Specificity of Irregular Red Blood Cell Antibodies Between First-Time Pregnant Women and Women With a History of Multiple Pregnancies Among 18,010 Chinese Women

Safety Issues Related To The Electronic Cross-Matching Of Blood In Mainland China A Prospective Cohort Study Involving Cross-Matching Of 40,228 Blood Samples

Human RBC Alloimmunization Evaluation after Exposure to Foreign E Antigen of the Rhesus System in Transfusion

[Analysis of the Irregular Antibodies of the Patients and Its Clinical Significance].

Result analysis of irregular antibody screening

Analysis on Screening of Irregular Antibodies in 66 013 Pregnant Women

Transfusion Support for a Patient with Alloanti-D and the RHD*DV.1 Allele.